Archive for the ‘Activism’ Category

U.S. Bill Moves to Ban Geoengineering Nationwide – But It’s Not All Roses

https://jonfleetwood.substack.com/p/new-federal-bill-authorizes-classified?

New Federal Bill Authorizes Classified NATO Genetic Engineering Deployment Strategy Linked to Bioweapons

H.R. 7653 authorizes NATO to “research, develop, and deploy biotechnology,” establishes international controls over dual-use systems the bill says could enable bioweapons, and permits secrecy.

Congress has introduced legislation that would place genetic engineering and synthetic biology technologies into NATO’s classified military planning structure, authorizing the alliance to “research, develop, and deploy biotechnology” under a new international biodefense framework governing tools the bill itself states could enable the development of bioweapons.

The bill, H.R. 7653, titled the Biodefense Diplomacy Enhancement Act, was introduced last week by U.S. Representative Keith Self (R-TX) and referred to the House Foreign Affairs Committee.

You can see Rep. Self’s top campaign contributors here, which include major U.S. military defense contractors Lockheed Martin, RTX (Raytheon), L3Harris Technologies, and Boeing—companies that operate extensively in military biodefense, biosurveillance, and biological threat detection programs.

If enacted, the legislation would formally move the technologies used to genetically engineer biological organisms into NATO’s coordinated defense infrastructure, where their development, deployment, and control would be governed through military and diplomatic channels.

This legislation comes as Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation, placing increased scrutiny on the genetic engineering technologies addressed in the bill.  (See link for article)

_____________

**Comment**

A key takeaway:

The legislation explicitly authorizes secrecy surrounding portions of these biotechnology strategies, raising transparency concerns.

Bill Remains in Committee

H.R. 7653 was introduced February 23, 2026, and referred to the House Foreign Affairs Committee.

It has not yet received a vote.

If enacted, the legislation would authorize NATO to develop, deploy, and govern genetic engineering and synthetic biology technologies under a classified biodefense strategy while establishing international control systems over technologies the bill itself states could enable the development of bioweapons.

For more:

Valneva’s Strategic Bet: Lyme Vaccine Holds Their Key to the Future (But Not Yours)

https://www.ad-hoc-news.de/boerse/news/ueberblick/valneva-s-strategic-bet-lyme-disease-vaccine-holds-key-to-future/68636490

Valneva’s Strategic Bet: Lyme Disease Vaccine Holds Key to Future

05.03.2026 | boerse-global.de

Valneva’s future hinges on its Lyme disease vaccine candidate, with final Phase 3 data expected in H1 2026. The stock has surged on anticipation, while its Chikungunya vaccine faces U.S. delays.

Valneva's Strategic Bet: Lyme Disease Vaccine Holds Key to Future - Foto: über boerse-global.de
Valneva’s Strategic Bet: Lyme Disease Vaccine Holds Key to Future – Foto: über boerse-global.de

At the TD Cowen Health Care Conference in Boston this week, executives from the French biotech firm Valneva outlined their strategic roadmap to institutional investors. The presentation by CEO Thomas Lingelbach and CFO Peter Buhler placed overwhelming emphasis on a single, pivotal asset: its candidate for a Lyme disease vaccine. The company’s future trajectory appears heavily dependent on this program, with final Phase 3 data anticipated in the first half of 2026.

A High-Stakes Clinical Catalyst

Valneva is advancing the pivotal Phase 3 trial for what could become the world’s only Lyme disease vaccine in late-stage development, in collaboration with pharmaceutical giant Pfizer. The U.S. Food and Drug Administration (FDA) has already granted the project Fast Track designation. Should the upcoming topline results confirm both efficacy and safety, Pfizer intends to submit applications for regulatory approval to the FDA and the European Medicines Agency (EMA) before the end of 2026.

This binary event is reflected in the equity’s performance. Valneva shares currently trade at €4.73, having nearly doubled in value over the past twelve months. This valuation incorporates significant market expectations for a positive trial outcome. Investor anxiety ahead of the data release is further evidenced by the stock’s substantial volatility, which stands above 53% on a 30-day basis. (See link for article)

_____________

**Comment**

Despite experts and advocates shouting at the top of their lungs that Valneva’s VLA15 Lyme vaccine is based on similar OspA-based tech as LYMErix which is responsible for 1000+ adverse reactions and ongoing severe complications, the FDA predictably gave it fast-track designation.  This should not surprise anyone.  The FDA could give two hoots about whether or not a ‘vaccine’ is truly ‘safe and effective.’

Just look at the clot shot for affirmation of this simple fact.  It has caused more adverse reactions and death than ANY other vaccine in the history of VAERS yet it’s still on the market amidst cries to pull it off the market, and despite being absolutely worthless with negative efficacy the more shots you get.

Injured By COVID Shot? CDC Wants to Hear From You asap

https://childrenshealthdefense.org/community/injured-covid-vaccine-submit-comment-acip-deadline-march-12/

Deadline March 12: Injured by a COVID Vaccine? ACIP Wants to Hear From You

The CDC’s vaccine advisory panel will hold its next meeting on March 18 and 19 in Atlanta. The panel is encouraging comments, oral or written, from the public. Specifically, the panel wants to hear from people who were injured by a COVID-19 vaccine.

By Children’s Health Defense Team

The Advisory Committee on Immunization Practices (ACIP) will hold its next meeting on March 18 and 19 at the Centers for Disease Control and Prevention (CDC) in Atlanta.

ACIP is inviting comments from the public. Specifically, the panel wants to hear from people who were injured by a COVID-19 vaccine.

If you have a story of vaccine injury, either your own or that of a loved one, now is the time to share it with ACIP.

The committee is requesting written comments on Docket No. CDC-2026-0199 by March 12 using the Federal eRulemaking Portal. Click here to submit a written comment.

If you’d like to provide oral comments, you must submit your request to speak no later than 11:59 p.m. EDT on March 12Click here to request to provide an oral comment.

This is a unique time in the history of the vaccine safety debate. Your voice matters.

Let’s let ACIP know we’re watching, listening, and we welcome the opportunity to weigh in on these crucial discussions!

For more:

Declassified Docs Link Bioweapon Program to Lyme Disease

http://

Radioactive Ticks

Dr. Robert Malone

March 5, 2026

Important point: Malone states that the Lone Star Tick has spread due to purposely deployed radio active ticks in Virginia by our government.  (It ain’t climate change!  Please hear me)

https://www.malone.news/p/declassified-documents-link-us-bioweapons

Declassified Documents Link U.S. Bioweapons Program to Lyme Disease Outbreak

Exclusive: Military released 282,800 radioactive ticks, suppressed co-infection research for 40 years

An extensive investigation based on declassified government documents and previously suppressed scientific research has uncovered compelling evidence that U.S. biological weapons programs contributed to the emergence of Lyme disease, which now affects hundreds of thousands of Americans annually.

The investigation reveals a pattern of concealment spanning six decades, including the systematic suppression of critical medical research and the release of nearly 300,000 radioactive ticks across Virginia to study how the disease-carrying insects would spread.

CIA Deployed Infected Ticks Against Cuba

Declassified documents and testimony from a CIA operative describe the 1962 deployment of infected ticks against Cuban sugarcane workers as part of Operation Mongoose, the Kennedy administration’s effort to destabilize Fidel Castro’s regime.

The operative, now in his seventies, told researchers that the “strangest thing he ever did was drop infected ticks on Cuban sugarcane workers” using C-123 transport aircraft flying nighttime missions “almost skimming the surface of the Caribbean to avoid Cuban radar.”

After returning from Cuba, the operative’s four-month-old son developed life-threatening fever requiring emergency surgery. His CIA commander advised him to “burn all the clothes you took to Cuba. Burn everything,” indicating contamination concerns.

The deployment was canceled when “Cuba’s shifting winds made accurate payload delivery difficult,” according to the operative’s account.

Massive Domestic Tick Experiments

Between 1966 and 1969, the U.S. military released 282,800 lone star ticks made radioactive with Carbon-14 across Virginia sites along bird migration routes. The radioactive marking allowed researchers to track the ticks’ spread using Geiger counters over several years.

Before these experiments, lone star ticks were not found above the Mason-Dixon Line. Within years of the Virginia releases, they had established populations on Long Island for the first time. Two tick experts consulted about these releases said they “were aghast” and “you’d never be able to do that now.”

The Swiss Agent Cover-Up

In 2014, researchers discovered extensive unpublished materials in the garage of deceased scientist Willy Burgdorfer, who identified the bacterium that causes Lyme disease. The materials revealed that Burgdorfer had found a second pathogen called “Swiss Agent” in Lyme patient blood samples from Connecticut and Long Island in the late 1970s.

Blood from Lyme patients showed “very strong reactions” to Swiss Agent testing, but this finding was completely omitted from Burgdorfer’s landmark 1982 study that identified the Lyme disease bacterium. The suppression of this research for over 40 years may have contributed to treatment failures in chronic Lyme patients.

Dr. Jorge Benach and Dr. Allen Steere, co-authors of the 1982 study, now acknowledge that Swiss Agent research “should be done” because “public health concerns warrant a closer look.”

Project 112: The Hidden Bioweapons Expansion

Defense Secretary Robert McNamara authorized Project 112 in 1962, creating what researchers describe as a bioweapons program “almost as large and secretive as the Manhattan Project.” The program involved 134 scheduled tests from 1962-1974 with production facilities capable of breeding 100 million infected mosquitoes monthly and 50 million fleas weekly.

The program’s existence was “categorically denied by the military” until 2000, when a CBS News investigation forced acknowledgment. Documents show the program involved “every branch of the U.S. armed services and intelligence agencies” with testing sites spanning multiple countries.

Operation Big Itch in 1954 successfully deployed 670,000 fleas from cluster bombs, proving arthropods could survive aerial deployment and “soon attached themselves to hosts.” The test validated bioweapons capable of covering “a battalion-sized target area and disrupt operations for up to one day.”

The Plum Island Connection

Plum Island Animal Disease Center sits just 13 miles from Lyme, Connecticut, where the disease was first identified. From 1952-1969, the facility was managed by the Army Chemical Corps for biological warfare research before transfer to the Department of Agriculture.

The facility “frequently conducted its experiments out of doors” with acknowledged containment failures where “test animals mingled with wild deer, test birds with wild birds.” Richard Endris maintained “over 200,000 soft and hard ticks of varying species in tick nurseries on Plum Island, personally collected from locations as far away as Cameroon, Africa.”

Wildlife regularly moved between Plum Island and the mainland. “Deer from Lyme regularly swam to Plum Island, and local birds flew there to feed on insects,” creating direct pathways for laboratory pathogens to reach wild populations.

Disease Emergence Timeline

The Long Island Sound region experienced an unprecedented outbreak of tick-borne diseases beginning in 1968:

  • 1968: First Eastern U.S. human babesiosis cases appear on Nantucket
  • 1968: Rocky Mountain spotted fever appears in Cape Cod region
  • 1970: Hundreds of Rocky Mountain spotted fever cases documented on Long Island
  • 1972: First 51 documented Lyme arthritis cases in Old Lyme, Connecticut

“By the 1990s, the eastern end of Long Island had by far the greatest concentration of Lyme disease,” according to one analysis. “If you drew a circle around the area of the world heavily impacted by Lyme disease, the center of that circle was Plum Island.”

Burgdorfer’s Cryptic Admissions

Willy Burgdorfer, who discovered the Lyme disease bacterium in 1982, spent most of his career developing tick-borne biological weapons before transitioning to civilian research. In 2013 video testimony, he confirmed participation in bioweapons research and “insinuated there had been an accidental release of some sort.”

After cameras stopped rolling, “Willy told us with a smile, ‘I didn’t tell you everything.’ But try as we might, we couldn’t get him to say more.” Before his death in 2014, he left a note stating “I wondered why somebody didn’t do something.”

In 2007, when documentary filmmakers attempted to interview Burgdorfer, a government scientist “pounded on the door” demanding to “sit in on this interview,” indicating ongoing official concern about his potential disclosures.

Pattern of Institutional Concealment

The investigation identified systematic concealment behaviors spanning multiple decades:

  • Project 112 denied for 50 years despite extensive documentation
  • Swiss Agent research suppressed despite public health relevance
  • Relevant documents kept classified long after security justifications expired
  • Congressional investigation requirements resisted
  • Laboratory origin questions characterized as “conspiracy theories”

(See link for article & comprehensive integrated multi-layered analysis of the issue)

_____________

**Comment**

An AI-enhanced retrospective analysis found:

  • phylogenetic gaps between ancient strains and the strains that emerged in the 60’s & 70’s (in other words, what we are infected with isn’t found in nature – it’s been tweaked in a lab)
  • co-infection clustering of three distinct diseases in the same geographical area and timeframe (but are never even considered, discussed or treated)
  • GMO signatures
  • distribution anomalies inconsistent with natural tick migration patterns (And it ain’t from climate change! It’s from man-made tick redistribution out of airplanes & migrating birds & animals)
  • suppression of the Swiss Agent indicating systematic research concealment

In short, it’s wide-spread systemic fraud perpetrated upon an unsuspecting public, yet the answer always presented is to have the very agencies behind this fraud do an investigation on themselvesIt will never happen.  ‘Dog and pony show’ comes to mind.

We’re on our own and the quicker we embrace this salient fact, the quicker we will get better.

For more:

Wisconsin Loses a Lyme Doctor & Advocate: Dr. Steven G. Meress

https://www.ueckerwitt.com/obituaries/dr-steven-meress

Dr. Steven G. Meress

October 11, 1953 — February 18, 2026

Fond du Lac

Dr. Steven G. Meress left the world unexpectedly on February 18, 2026, leaving behind a legacy of pure love and compassion for his family, friends and his many patients. Born to Ernest and Joyce (LeFebvre) Meress on October 11, 1953, in Marshfield, WI, he died at Aurora BayCare in Green Bay, WI.

He married Lori Kinzler on April 15, 2011, and after their retirement, began a life filled with the joys of grandparenting and international travel.

Dr. Meress attended the University of Wisconsin-Madison from 1971 to 1982, earning a Bachelor of Science degree in Medical Microbiology, a Master’s in Immunology, and completed the Physician Assistant Program. Continuing his medical education at St. George’s University School of Medicine in Grenada, West Indies, and New York, NY, he earned his Doctor of Medicine degree with Honors in 1986. In 1989, he completed his Internal Medicine residency at the University of Wisconsin-Marshfield Clinic in Marshfield, WI.

Dr. Meress spent the next 20 years practicing emergency, hospice, and prison medicine in Fond du Lac and surrounding areas.

In 1999, Dr. Meress and his late wife, Julie (Spallas) Meress, responding to a need for private integrative medicine in the community, founded Fox Valley Wellness Center in Fond du Lac, WI. During one of the most exciting and fulfilling chapters of Steve’s career, he soon realized the significant gap in care for patients suffering from Lyme disease and its co-infections, which became a primary focus of the practice. The clinic flourished, serving patients from across the United States and beyond.

After Julie’s death in 2008, Dr. Meress, with the unwavering support of his dedicated staff, continued his mission and expanded the practice’s impact. In 2020, the clinic was sold to Forum Health, a nationwide provider of functional medicine services. Energized by this new chapter in his career, Dr. Meress remained actively involved in patient care as well as in leadership and mentoring roles until his full retirement in October 2024.

Throughout his distinguished career, Steve also proudly served as a Major in the Army Reserve and National Guard. He combined his love of medicine and beautiful cars by serving for many years as track physician at Road America in Elkhart Lake, WI. He was an active leader in International Lyme and Associated Diseases Society (ILADS), frequently serving as keynote speaker at international conferences. A trusted and respected resource for physicians treating Lyme patients, Steve generously shared his knowledge and experience, receiving numerous accreditations and awards throughout his career. As a lifelong learner, he genuinely cared for his patients and was deeply committed to serving others.

Above all, Steve cherished and prioritized his family. He is survived by his adoring wife, Lori Meress; his beautiful daughter, Jennifer (Dean) Wilson; and his granddaughters, Carmella and Eleanor of Shawano, WI. He is further survived by his stepsons, Brian (Abby) Carson of Santa Rosa, CA; Tony (Amy) Carson of Eugene, OR; and granddaughters Ayla and Azlynn Carson. “Papi,” you will forever remain in our hearts.

He is also survived by his beloved nieces, nephews and many friends. Steve was preceded in death by his parents; his dear brother, Ernest Meress, Jr.; and his recently departed sister, Mary Jane Remitz.

Our sorrow is deep, yet deeply grounded in our love for this remarkable man. Words cannot fully express the gratitude we carry for the years, the wisdom, the laughter, and the unwavering love Steve gave so freely. Reflecting God’s love, he cared for others with compassion, service, and devotion. While his absence leaves an ache that will be felt every day, and though we grieve profoundly, we trust Steve is now at peace in the presence of the Lord, reunited with those who have gone before him. This is not goodbye, but until we meet again.

In lieu of flowers, the family requests donations to the non-profits The Gratitude Club/Phoenix Nest or the Holy Family Catholic Community Warming Shelter, both in Fond du Lac.

Visitation for Steve will be from 10:00 AM – 1:00 PM, Thursday, February 26, 2026, at Uecker-Witt Funeral Home. A memorial service will be held, beginning at 1:00 PM. Cremation has taken place.

Services are in the care of Uecker-Witt Funeral Home, 524 North Park Avenue, Fond du Lac, WI, 54935. Additional information and guestbook can be found at ueckerwitt.com

To order memorial trees or send flowers to the family in memory of Dr. Steven G. Meress, please visit our flower store.